Not currently recruiting at UCSF
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Joel Palefsky, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Joel Palefsky, MD
Joel Palefsky, M.D., C.M., F.R.C.P.(C). Professor of Medicine and Infectious Diseases at the University of California San Francisco School of Medicine. He is an internationally recognized expert on the molecular biology, treatment, pathogenesis and natural history of anogenital human papillomavirus infections, particularly in the setting of HIV infection.
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Frantz Viral Therapeutics, LLC
- ID
- NCT05555862
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 48 study participants
- Last Updated